Abstract
Activation of the inflammatory response system has been related to the pathophysiology of schizophrenia by several recent studies. Schizophrenic patients have varied levels of proinflammatory cytokines, such as interleukin (IL)-1,-6, and tumor necrosis factor (TNF)α in their peripheral blood or cerebrospinal fluid.1–6 These cytokines can modify the metabolism of neurotransmitters, influence neural development, and IL-1 has been implicated in acute, and, on the other hand, chronic neurodegeneration.7,8 They could therefore be of primary pathogenic importance, either in the acute disease or during those stages of brain development which possibly influence the sensitivity of a person to schizophrenia in later life. The cytokine regulation of brain development and its possible neuroimmune involvement in the pathogenesis of schizophrenia has been raised.9 One indication of the pathogenic role of IL-1 in schizophrenia would be a demonstration of the difference between schizophrenic patients and healthy controls at the gene level. Therefore we analyzed the polymorphism of the IL-1 gene complex in 50 schizophrenic patients and in 400 healthy blood donors. The following allelisms were analyzed: IL-1β gene: base exchange polymorphisms at the positions −511 (relative to the transcriptional start site); IL-1α gene: base exchange polymorphism at the position −889; IL-1 receptor antagonist (IL-1RA) gene: variable numbers of 86-base pair tandem repeats in intron 2. The frequencies of the IL-1β (−511) allele 1, IL-1α (−889) allele 2, and IL-1RA allele 1 were somewhat, but not significantly, higher in the schizophrenic patients as compared to the controls. These alleles are known to be located on the same haplotype.10 The number of carriers of this haplotype was significantly higher in the schizophrenia patients (17/50 vs 81/400) than in the controls (P = 0.026, χ2). The frequencies of this haplotype were 0.38 and 0.27, respectively (P = 0.0266, χ2). The number of homozygotes of this haplotype was significantly higher in the schizophrenia patients (P = 0.0006, χ2). These data suggest that the cytokine aberrations in schizophrenia are, at least partly, genetically determined.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Katila, H., Hänninen, K. & Hurme, M. Polymorphisms of the interleukin-1 gene complex in schizophrenia. Mol Psychiatry 4, 179–181 (1999). https://doi.org/10.1038/sj.mp.4000483
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.mp.4000483
Keywords
This article is cited by
-
Interleukin-1 receptor antagonist (IL-1RA) and interleukin-4 (IL-4) variable number of tandem repeat polymorphisms in schizophrenia and bipolar disorder: an association study in Turkish population
Egyptian Journal of Medical Human Genetics (2022)
-
Neuroinflammation in schizophrenia: the role of nuclear factor kappa B
Translational Psychiatry (2021)
-
Environmental regulation of the chloride transporter KCC2: switching inflammation off to switch the GABA on?
Translational Psychiatry (2020)
-
Interleukin-1beta Promoter (−31T/C and −511C/T) Polymorphisms in Major Recurrent Depression
Journal of Molecular Neuroscience (2011)
-
The Genetics of Alzheimer’s Disease in Brazil: 10 Years of Analysis in a Unique Population
Journal of Molecular Neuroscience (2009)